Two technologies have come together to allow for a new kind of radiation treatment known as simultaneous integrated boost (SIB), or, more informally, “dose painting.” … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: boost, dose painting, integrated, radiation, SIB, simultaneous | 5 Comments »
The first randomized clinical trial to prove that brachy boost radiotherapy had better oncological outcomes among high-risk patients was the one published by Sathya et al. in 2005. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: boost, brachy, high, intermediate, outcome, radiation, risk, survival | 6 Comments »
The ASCENDE-RT trial showed that oncological outcomes were improved among both intermediate-risk and high-risk men who were treated with external beam radiation (EBRT) and a brachytherapy boost (LDR-BT) to the prostate and adjuvant androgen deprivation therapy (ADT) (see this link). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: boost, brachytherapy, effectiveness, risk, safety, Treatment, type | Leave a comment »
Several randomized clinical trials have established the superior oncological outcomes of the combination of external beam radiotherapy with a high-dose-rate brachytherapy boost (see this link). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: boost, brachytherapy, high, intermediate, progression-free, risk, survival | 1 Comment »
In August last year, Kishan et al. showed a preliminary analysis of oncological outcomes among patients diagnosed with Gleason score 9 and 10 and treated with brachy boost therapy (EBRT + BT), external beam radiation therapy alone (EBRT), or surgery (see this link). … READ MORE …
Filed under: Management, Treatment | Tagged: "high risk", boost, brachy, BT, EBRT, outcome | 8 Comments »
A retrospective analysis of oncological outcomes among modern-era patients with a Gleason score of 9 or 10 demonstrates a clear advantage to a combination of external beam radiation therapy (EBRT) with a brachytherapy (BT) boost to the prostate and short–term androgen deprivation therapy (ADT). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: "high risk", ADT, boost, brachytherapy, comparison, outcome, radiation, surgery | 12 Comments »
Recently we have seen evidence of improved cancer control in high-risk patients treated with external beam radiotherapy with a brachytherapy boost to the prostate. This has been demonstrated with both HDR brachytherapy boost and with LDR brachytherapy boost. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: body, boost, radiation, stereotactic, therapy | 15 Comments »
At last week’s Genitourinary Cancers Symposium, Amini et al. presented the results of a data analysis that addresses the question of which kind of high-dose radiation therapy has the best cancer control rates … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: boost, brachytherapy, high-dose, radiation, therapy, very high-dose | 2 Comments »
The ASCENDE-RT randomized clinical trial demonstrated that the combination of external beam radiation therapy with a brachytherapy boost (EBRT + BT) significantly reduced biochemical progression-free survival. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: boost, brachytherapy, BT, EBRT, external beam, high, intermediate, mortality, outcome, radiation, risk | 3 Comments »
Two technologies have been brought together to allow for a new kind of radiation treatment known as simultaneous integrated boost (SIB) or, more informally, “dose painting.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: boost, dose, integrated, painting, radiation, SIB, simultaneous | Leave a comment »
News reports (and apparently a media release) have been suggesting that ‘A prostate cancer treatment using permanently implanted radioactive “seeds” doubles rates of 5-year tumor-free survival compared with conventional high-dose radiotherapy.’ Unfortunately, these reports are somewhat — or perhaps very — misleading. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ASCENDE-RT, boost, brachytherapy, external beam, low-dose, radiation | 9 Comments »
Numerous retrospective analyses have suggested that the combination of external beam radiation therapy (EBRT) with a low-dose-rate brachytherapy (LDRBT) boost is highly effective in controlling prostate cancer in unfavorable-risk patients. … READ MORE …
Filed under: Management, Treatment | Tagged: boost, brachytherapy, external beam, low-dose-rate, radiation, risk | 3 Comments »
There was an intriguing paper in the November 2013 issue of the journal Prostate suggesting that intermittent dosing with testosterone in between doses of androgen deprivation therapies may actually help men in the early stages of castration resistance to respond better to treatment over time. … READ MORE …
Filed under: Uncategorized | Tagged: boost, castration-resistance, CRPC, hypothesis, model, teststerone | 4 Comments »
New data from the radiotherapy group at the University of Califronia, San Francisco suggests that stereotactic body radiation (SBRT) can be used to deliver a “boost” of focused radiation after external beam radiation therapy (EBRT). High dose rate (HDR) brachytherapy has also been used in this way in the past. … READ MORE …
Filed under: Management, Treatment | Tagged: boost, SBRT, stereotactic body radiation therapy | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 